🇺🇸 FDA
Pipeline program

Mixed amphetamine salts (ADDERALL XR)

SLI381-404

Approved small_molecule completed

Quick answer

Mixed amphetamine salts (ADDERALL XR) for ADHD is a Approved program (small_molecule) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).

Program details

Company
Takeda Pharmaceuticals International AG
Indication
ADHD
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials